Abstract
The objective of this study is to evaluate the serum dosage of the soluble HLA-G in patients with and without pelvic endometriosis, and relation these data with the clinical information, stage of the disease (ASRM, 1996), phase of the menstrual cicle, site of the disease and the histological classification of endometriosis.